StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) stock

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.51−0.05 (-3.51%)

Close on Nov 17, 2026Market cap $2.77MP/E –Yield –

NeuroSense Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for NeuroSense Therapeutics

NeuroSense Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NeuroSense Therapeutics figures

See a number that looks wrong?